Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors Board expansion supports ongoing development of cytoDRiVE™ programs and external collaborations Sept. 3, 2020, 08:00 AM […]
Obsidian Therapeutics Develops and Shares Safe Workplace Productivity Solution in Response to COVID19 Implementation has enabled Obsidian to remain on track to meet development targets, while […]
Obsidian Therapeutics Appoints Anders Götzsche to Board of Directors March 3, 2020, 07:00 AM Eastern Standard Time CAMBRIDGE, Mass., March 3, 2020 – Obsidian Therapeutics, a biotechnology […]
Obsidian Therapeutics Announces Formation of Scientific Advisory Board Members will help to guide the development strategy of existing pipeline as well as identify innovative applications for […]
Obsidian Therapeutics Announces Expansion of Leadership Team Additions support Obsidian’s active program development, operational build-out and ongoing regulatory discussions Nov. 12, 2019, 08:00 AM Eastern Standard […]